| MolName | (E)-4-[3-(3-nitrophenyl)-5-phenyl-3,4-dihydropyrazol-2-yl]-4-oxobut-2-enoic acid |
| MolecularFormula | C19H15N3O5 |
| Smiles | [O-][N+](c1cc(C(C2)N(C(/C=C/C(O)=O)=O)N=C2c2ccccc2)ccc1)=O |
| InChI | InChI=1S/C19H15N3O5/c23-18(9-10-19(24)25)21-17(14-7-4-8-15(11-14)22(26)27)12-16(20-21)13-5-2-1-3-6-13/h1-11,17H,12H2,(H,24,25)/t17-/m0/s1 |
| InChIK | ZNXCVFGTISGIIR-KRWDZBQOSA-N |
| TotalMolweight | 365.344 |
| Molweight | 365.344 |
| MonoisotopicMass | 365.101172 |
| CLogP | 1.6871 |
| CLogS | -3.863 |
| H Acceptors | 8 |
| H Donors | 1 |
| TotalSurfaceArea | 271.07 |
| Relative PSA | 0.31232 |
| PolarSurfaceArea | 115.79 |
| Druglikeness | -1.699 |
| Mutagenic | none |
| Tumorigenic | none |
| Reproductive Effective | none |
| Irritant | none |
| Nasty Functions | aromatic nitro |
| Shape Index | 0.44444 |
| Fragments | 1 |
| Non HAtoms | 27 |
| NonCHAtoms | 8 |
| Electronegative Atoms | 8 |
| StereoCenters | 1 |
| Rotatable Bond | 5 |
| Rings Closures | 3 |
| Small Rings | 3 |
| Aromatic Rings | 2 |
| Aromatic Atoms | 12 |
| Sp3Atoms | 4 |
| Symmetricatoms | 2 |
| AcidicOxygens | 2 |
| StereoCon | racemate |
Click to Load Molecule:
1 - (E)-4-[3-(3-nitrophenyl)-5-phenyl-3,4-dihydropyrazol-2-yl]-4-oxobut-2-enoic acid | 2 - (E)-4-[3-(3-nitrophenyl)-5-phenyl-3,4-dihydropyrazol-2-yl]-4-oxobut-2-enoic acid